This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jing, L. Articles by Luo, J.-H. Search for Related Content PubMed PubMed Citation Articles by Jing, L. Articles by Luo, J.-H.

(American Journal of Pathology. 2004;164:1799-1806.)
© 2004 American Society for Investigative Pathology

Expression of Myopodin Induces Suppression of Tumor Growth and Metastasis

Ling Jing^*, Lijun Liu^*, Yan Ping Yu^*, Rajiv Dhir^*, Marie Acquafondada^*, Doug Landsittel, Kathleen Cieply^*, Alan Wells^* and Jian-Hua Luo^*

From the Department of Pathology^* and the Biostatistic Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Myopodin was previously reported as a gene that was frequently deleted in prostate cancer. This gene shares significant homology with a cell shape-regulating gene, synaptopodin. Myopodin was shown to bind actin and to induce actin bundling when cells were stimulated. To clarify the functional role of myopodin in prostate cancer, several assays were performed to evaluate the tumor suppression activity of myopodin. Our results indicate that myopodin inhibits tumor growth and invasion both in vitro and in vivo. The activity of tumor suppression of myopodin is located at the C-terminus region. To further evaluate the role of myopodin in suppressing the invasiveness of prostate cancer, an expression analysis of myopodin protein was performed in prostate tissues. The results indicate that down-regulation of myopodin expression occurs mostly in invasive stages of prostate cancer, implying a potential invasion suppression role for myopodin in prostate cancer. In addition, hemizygous deletion and down-regulation of myopodin expression occur in three aggressive prostate cancer cell lines. All these results support the hypothesis that myopodin functions as a tumor suppressor gene to limit the growth and to inhibit the metastasis of cancer cells.

This article has been cited by other articles:

				Y.-K. Shi, Y. P. Yu, Z.-H. Zhu, Y.-C. Han, B. Ren, J. B. Nelson, and J.-H. Luo MCM7 Interacts with Androgen Receptor Am. J. Pathol., December 1, 2008; 173(6): 1758 - 1767. [Abstract] [Full Text] [PDF]

				Y. P. Yu, G. Yu, G. Tseng, K. Cieply, J. Nelson, M. Defrances, R. Zarnegar, G. Michalopoulos, and J.-H. Luo Glutathione Peroxidase 3, Deleted or Methylated in Prostate Cancer, Suppresses Prostate Cancer Growth and Metastasis Cancer Res., September 1, 2007; 67(17): 8043 - 8050. [Abstract] [Full Text] [PDF]

				B. Ren, Y. P. Yu, G. C. Tseng, C. Wu, K. Chen, U. N. Rao, J. Nelson, G. K. Michalopoulos, and J.-H. Luo Analysis of Integrin {alpha}7 Mutations in Prostate Cancer, Liver Cancer, Glioblastoma Multiforme, and Leiomyosarcoma J Natl Cancer Inst, June 6, 2007; 99(11): 868 - 880. [Abstract] [Full Text] [PDF]

				Y. P. Yu and J.-H. Luo Myopodin-mediated suppression of prostate cancer cell migration involves interaction with zyxin. Cancer Res., August 1, 2006; 66(15): 7414 - 7419. [Abstract] [Full Text] [PDF]

				K. Yano, K. Imai, A. Shimizu, and T. Hanashita A new method for gene discovery in large-scale microarray data Nucleic Acids Res., March 14, 2006; 34(5): 1532 - 1539. [Abstract] [Full Text] [PDF]